bit.bio

Showing 2 posts of 2 posts found.

bit.bio expands human heart cell portfolio through myriamed partnership

September 30, 2026
Biotechnology, bit.bio, drug discovery, myriamed, safety testing

bit.bio has partnered with German biotechnology company myriamed to offer cryopreserved human induced pluripotent stem cell (iPSC)-derived cardiomyocytes for drug …

Bit.bio announces cell therapy pipeline

November 8, 2023
Medical Communications Hepatology, bit.bio, cell therapy, liver failure

Bit.bio has announced its cell therapy pipeline as well as having shared its lead cell therapy candidate, preparing to enter …

The Gateway to Local Adoption Series

Latest content